UALCAN was utilized to analyze the protein expression of risk factors in CPTAC ccRCC samples; we found that only TYMP exhibited a detectable upregulated protein level in ccRCC patients (Supplementary Figure S4A). Here, TYMP is linked to nonpapillary renal cell carcinoma.